Inclusion body myositis and primary Sjögren syndrome [3];Miositis por cuerpos de inclusión y síndrome de Sjögren primario [3]

Medicina Clinica

Volumn 120, Issue 8, 2003, Pages 318-319

  Pardos Gea, Josep ^a   O'Callaghan, Albert Selva ^a   Sans Valeta, Jordi ^a   Grau Junyent, Josep M ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE; PREDNISONE;

AGED; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; LABORATORY TEST; LETTER; MUSCLE BIOPSY; SJOEGREN SYNDROME; TREATMENT OUTCOME;

EID: 12244304873     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13043904     Document Type: Letter

References (10)

1. Amato AA, Gronseth GS. Inclusion body miositis: clinical and pathological boundaries. Ann Neurol 1996;40:581-6.
2. Miró O, Laguno M, Alonso JR, Casademont J, Herrero C, Selva A, et al. Evolución de las miopatías inflamatorias idiopáticas: complicaciones, supervivencia y factores pronósticos. Med Clin (Barc) 1999;112:521-6.
3. Vrethem M, Lindvall VM, Holmgren H, Henriksson K-G, Lindstrom F, Ernerudh J. Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological, and muscle biopsy results. Acta Neurol Scand 1990;82:126-31.
4. Kanellopoulos P, Baltoyiannis C, Tzioufas AG. Primary Sjögren's syndrome associated with inclusion body myositis. Rheumatology 2002;41:440-4.
5. Manthorpe R. Sjögren's syndrome criteria. American-European and Japanese Groups' criteria compared and contrasted. Ann Rheum Dis 2002;61:482-4.
6. Askanas V, Engel WK. New advances in inclusion body myositis. Curr Opin Rheumatol 1993;5:753-41.
7. Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Labrador-Horrillo M, Grau-Junyent J, Sotans Laque R, Vilardell-Tarrés M. Anti-PM-Sel antibodies in a patient with inclusion body myositis. Rheumatology (Oxford) 2003; [en prensa].
8. Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998;21:115-7.
9. Hengstman GJD, Ter Laak HJ, Van Engelen BGM, Van Venrooij WJ. Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone. J Neurol Neurosurg Psychiatry 2001;70:706-11.
10. McCoy AL, Bubb MR, Plotz PH, Davis JC. Inclusion body myositis long after dermatomyositis: a report of two cases. Clin Exp Rheumatol 1999; 17:235-9.